(Date:11/30/2009)...e-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasd... Administration (FDA) has granted orphan drug desi...ridine phosphate, for the rare autoimmune disease ... has previously received orphan drug designation i...or Medicinal Products for Human Use of the Europea...
(Date:11/30/2009)...e-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nas...ass of platinum-based anti-tumor compounds, termed...r potency and activity compared to currently avail...ty to overcome cisplatin-resistance in cancer cell...led "Novel Bis-platinum Complexes Endowed with an ...
(Date:11/30/2009)...swire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a,le...evice research and,development outsourcing company...nnounced that it had been selected to the Deloitte...consecutive year. The list recognizes the 50,faste... and telecommunications,industries based on revenu...
(Date:11/30/2009)...ERDAM, November 30 Elsev...medical and technical products and services,today...hensive biomedical,database which holds over 20 mi... peer reviewed journals. , Embase has lon...edical,and pharmaceutical insights. Now, new devel...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3... Corporation,(Nasdaq: BPUR ) today announced that... Healthcare Products Regulatory Agency (MHRA) is s... of the meeting is to clarify the issues outlined ...e United Kingdom,s Commission,on Human Medicines r...uthorization for Hemopure(R). The issues relate to...
...red Hutchinson Cancer,Research Center have a lead ... the first systematic surveillance program of men ...to help determine when to wait and when,to treat t...y Foundation,and the National Cancer Institute., ...nical Research and,Human Biology divisions, will l...
...mployees were recognized,for their significant con...nnual TWIN Awards Dinner held May 1, 2008. Honored...ncology, Drug Regulatory Affairs, and Sherrie,Piet...mistry., "These individuals exemplify the best an...ontributions to the company,s success, and to the ...
Other Biology Technology:Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 2Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 3When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 2When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 3Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 2Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 3Phosphate Colorimetric Assay Kit, PiBlue from BioAssay Systems
Phosphate Colorimetric Assay Kit from BioAssay Systems
Varian 1200L GC/MS from Varian, Inc.
EnzChek cellulase substrate *blue fluorescent, 339/452 from Invitrogen
Biology Products: